CCPS vs CCD: Which Instrument Is Better for Startups?
When an Indian startup raises its first institutional cheque, the term sheet almost always lands on one of two instruments: Compulsorily Convertible Debentures (CCDs) or Compulsorily Convertible Preference Shares (CCPS). Both eventually turn into equity, both are recognized under India's foreign investment rules, and both show up constantly in seed and early-stage rounds. But they're structured very differently, and picking the wrong one for a given stage or investor can create friction well before the actual conversion happens.
What Each Instrument Actually Is?
A CCD is a debt instrument at issuance the company owes the investor, typically with a coupon or interest component but it's required to convert into equity shares by a specified date or trigger event, rather than staying debt indefinitely. Because it starts life as debt, it's often the more familiar structure for investors used to debenture documentation, and it can defer equity dilution slightly longer than an instrument that behaves like equity from day one.
A CCPS is a preference share from the beginning. It provides rights, usually a liquidation preference, before common shareholders and often anti‑dilution protection. It automatically turns into equity shares on the terms that are agreed. This is the instrument institutional VCs are generally most comfortable with, since it aligns closely with how priced equity rounds are typically structured globally.
Why Both Are FEMA-Recognized, and SAFEs Often Aren't
This distinction matters more than founders often realize. India's foreign investment rules only permit a small, defined list of "capital instruments" for receiving foreign money equity shares, CCPS, CCDs, and share warrants. A plain SAFE note, the instrument common in US fundraising, isn't on that list. When foreign investment comes in it must be issued against a recognized capital instrument within a set timeline. Properly reported. If a startup accepts money through an unrecognized instrument it can create a compliance gap. That compliance gap may surface later during the next round’s due diligence.
This is exactly why CCDs and CCPS remain the default choices for foreign-backed Indian startups, and why India-specific adaptations of SAFE-style instruments are typically structured as CCPS under the hood, to stay within this recognized framework.
Which One Actually Fits Which Stage?
In practice, CCDs appear often in smaller earlier rounds. Seed and pre-Series A. And in situations where an investor feels comfortable, with debenture‑style paperwork or where postponing formal equity dilution for a short time is truly useful. CCPS becomes the more common choice from Series A onward, largely because institutional VCs are generally more comfortable with the liquidation preference and anti-dilution protection that come naturally with a preference share structure, and because the documentation aligns more closely with standard priced-round practice.
Neither instrument is inherently better; the right fit depends on the round's size, the investor's own institutional preferences, and how much dilution the founders are comfortable taking on before the instrument actually converts.
Why Valuation Still Matters for Both
Whichever instrument is chosen, the conversion price has to be fixed properly at issuance, and it generally can't fall below the fair market value determined at that point. For any round involving a foreign investor, this valuation must be certified by a SEBI-registered merchant banker or a chartered accountant, using an internationally accepted approach such as DCF, NAV, or a comparable companies analysis. Getting this valuation wrong doesn't just risk a compliance headache — it can distort the actual economics of the instrument once conversion happens, which is precisely the moment founders and early investors feel the impact most directly.
CCDs and CCPS both address the issue. Connecting early-stage funding to a clear future equity stake. But they are not the same thing. The decision, between them should be based on the details of the funding round not on routine or what is easiest. Founders raising their first institutional round are usually better served understanding what their specific investor expects, what stage they're actually at, and getting the underlying valuation right, rather than defaulting to whichever instrument came up in the last funding conversation they had.
